Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mickael Decressac

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Neurobiology of Disease|July 21, 2009
Anatomical and functional reconstruction of the nigrostriatal pathway by intranigral transplantsAfsaneh Gaillard, Mickael Decressac, Isabelle Frappé, et al.
Neurotoxicity Research|February 10, 2010
Environmental enrichment does not reduce the rewarding and neurotoxic effects of methamphetamineNathalie Thiriet, Benjamin Gennequin, Virginie Lardeux, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 23, 2015
Nurr1 and Retinoid X Receptor Ligands Stimulate Ret Signaling in Dopamine Neurons and Can Alleviate α-Synuclein Disrupted Gene ExpressionNikolaos Volakakis, Katarina Tiklova, Mickael Decressac, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 2, 2016
Targeting α-synuclein: Therapeutic optionsBenjamin Dehay, Mickael Decressac, Mathieu Bourdenx, et al.
Neurobiology of Aging|August 6, 2011
Neuroprotection by neuropeptide Y in cell and animal models of Parkinson's diseaseMickael Decressac, Stéphanie Pain, Pierre-Yves Chabeauti, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2013
Transcription factor Nurr1 maintains fiber integrity and nuclear-encoded mitochondrial gene expression in dopamine neuronsBanafsheh Kadkhodaei, Alexandra Alvarsson, Nicoletta Schintu, et al.
Acta Neuropathologica Communications|December 16, 2015
Cyclosporin promotes neurorestoration and cell replacement therapy in pre-clinical models of Parkinson's diseaseAnna Tamburrino, Madeline J Churchill, Oi W Wan, et al.
Biological Psychiatry|September 23, 2015
Alpha-Synuclein Produces Early Behavioral Alterations via Striatal Cholinergic Synaptic Dysfunction by Interacting With GluN2D N-Methyl-D-Aspartate Receptor SubunitAlessandro Tozzi, Antonio de Iure, Vincenza Bagetta, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Neurobiology of Disease|July 21, 2009
Anatomical and functional reconstruction of the nigrostriatal pathway by intranigral transplantsAfsaneh Gaillard, Mickael Decressac, Isabelle Frappé, et al.
Neurotoxicity Research|February 10, 2010
Environmental enrichment does not reduce the rewarding and neurotoxic effects of methamphetamineNathalie Thiriet, Benjamin Gennequin, Virginie Lardeux, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 23, 2015
Nurr1 and Retinoid X Receptor Ligands Stimulate Ret Signaling in Dopamine Neurons and Can Alleviate α-Synuclein Disrupted Gene ExpressionNikolaos Volakakis, Katarina Tiklova, Mickael Decressac, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 2, 2016
Targeting α-synuclein: Therapeutic optionsBenjamin Dehay, Mickael Decressac, Mathieu Bourdenx, et al.
Neurobiology of Aging|August 6, 2011
Neuroprotection by neuropeptide Y in cell and animal models of Parkinson's diseaseMickael Decressac, Stéphanie Pain, Pierre-Yves Chabeauti, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2013
Transcription factor Nurr1 maintains fiber integrity and nuclear-encoded mitochondrial gene expression in dopamine neuronsBanafsheh Kadkhodaei, Alexandra Alvarsson, Nicoletta Schintu, et al.
Acta Neuropathologica Communications|December 16, 2015
Cyclosporin promotes neurorestoration and cell replacement therapy in pre-clinical models of Parkinson's diseaseAnna Tamburrino, Madeline J Churchill, Oi W Wan, et al.
Biological Psychiatry|September 23, 2015
Alpha-Synuclein Produces Early Behavioral Alterations via Striatal Cholinergic Synaptic Dysfunction by Interacting With GluN2D N-Methyl-D-Aspartate Receptor SubunitAlessandro Tozzi, Antonio de Iure, Vincenza Bagetta, et al.
Pageof 2